Home
>
National Drug Code (NDC)
>
ZYPREXA
ZYPREXA - 0002-7635-11 - (Olanzapine pamoate)
Drug Information of ZYPREXA
| Product NDC: | 0002-7635 |
| Proprietary Name: | ZYPREXA |
| Non Proprietary Name: | Olanzapine pamoate |
| Active Ingredient(s): | & nbsp; Olanzapine pamoate |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ZYPREXA
| Product NDC: | 0002-7635 |
| Labeler Name: | Eli Lilly and Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022173 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100301 |
Package Information of ZYPREXA
| Package NDC: | 0002-7635-11 |
| Package Description: | 1 KIT in 1 CARTON (0002-7635-11) * 1.4 mL in 1 VIAL (0002-7658-63) * 3 mL in 1 VIAL (0002-7622-63) * 1.4 mL in 1 VIAL (0002-7658-01) * 3 mL in 1 VIAL (0002-7622-01) |
NDC Information of ZYPREXA
| NDC Code | 0002-7635-11 |
| Proprietary Name | ZYPREXA |
| Package Description | 1 KIT in 1 CARTON (0002-7635-11) * 1.4 mL in 1 VIAL (0002-7658-63) * 3 mL in 1 VIAL (0002-7622-63) * 1.4 mL in 1 VIAL (0002-7658-01) * 3 mL in 1 VIAL (0002-7622-01) |
| Product NDC | 0002-7635 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Olanzapine pamoate |
| Dosage Form Name | KIT |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20100301 |
| Marketing Category Name | NDA |
| Labeler Name | Eli Lilly and Company |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
